000141843 001__ 141843
000141843 005__ 20240229105133.0
000141843 037__ $$aDKFZ-2018-02111
000141843 1001_ $$0P:(DE-HGF)0$$aDemoen, L$$b0
000141843 245__ $$aLong-term treatment of SGBS preadipocytes with Withaferin A: Effects on DNA methylation and adipocyte differentiation
000141843 260__ $$c2018
000141843 3367_ $$2DataCite$$aOutput Types/Supervised Student Publication
000141843 3367_ $$02$$2EndNote$$aThesis
000141843 3367_ $$2BibTeX$$aMASTERSTHESIS
000141843 3367_ $$2DRIVER$$amasterThesis
000141843 3367_ $$0PUB:(DE-HGF)19$$2PUB:(DE-HGF)$$aMaster Thesis$$bmaster$$mmaster$$s1544101654_5411
000141843 3367_ $$2ORCID$$aSUPERVISED_STUDENT_PUBLICATION
000141843 502__ $$aMasterarbeit,  	University of Antwerp, 2018$$bMasterarbeit$$c 	University of Antwerp$$gFaculty of Pharmaceutical, Biomedical and Veterinary Sciences
000141843 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000141843 909CO $$ooai:inrepo02.dkfz.de:141843$$pVDB
000141843 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000141843 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000141843 9141_ $$y2018
000141843 9201_ $$0I:(DE-He78)C010-20160331$$kC010$$lEpigenomik und Krebsrisikofaktoren$$x0
000141843 980__ $$amaster
000141843 980__ $$aVDB
000141843 980__ $$aI:(DE-He78)C010-20160331
000141843 980__ $$aUNRESTRICTED